Intriguingly, clinical investigations have shed light on the prognostic implications of PTGS2 protein expression patterns in gastric cancer patients, underscoring its association with distinct clinicopathological features including histological subtype, tumor location, size, and lymph node involvement. This evidence concerns the gene PTGS2 and neoplasm.